Beyond the 90-90-90: Refocusing HIV prevention as part of the global HIV response: Refocusing

Journal of the International AIDS Society

Volumn 19, Issue 1, 2016, Pages

  Baggaley, Rachel ^a   Dalal, Shona ^a   Johnson, Cheryl ^a   Macdonald, Virginia ^a   Mameletzis, Ioannis ^a   Rodolph, Michelle ^a   Figueroa, Carmen ^a   Samuelson, Julia ^a   Verster, Annette ^a   Doherty, Meg ^a   Hirnschall, Gottfried ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

antiretroviral therapy; HIV prevention; key populations; PrEP; voluntary medical male circumcision

Indexed keywords

ANTIRETROVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CIRCUMCISION; COST EFFECTIVENESS ANALYSIS; DEATH; EPIDEMIC; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; LONG TERM CARE; MANDATORY TESTING; MORBIDITY; MORTALITY; NONHUMAN; PHYLOGENY; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; REVIEW; SCALE UP; UNITED NATIONS; VIRUS LOAD; VIRUS TRANSMISSION; ADULT; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; MALE; YOUNG ADULT;

ADULT; CIRCUMCISION, MALE; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; PRE-EXPOSURE PROPHYLAXIS; UNITED NATIONS; YOUNG ADULT;

EID: 85024381894     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.19.1.21348     Document Type: Review

References (24)

1. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva, Switzerland: World Health Organization; 2015.
2. Joint United Nations Program on HIV/AIDS (UNAIDS). Global AIDS update. Geneva, Switzerland: UNAIDS; 2016.
3. Joint United Nations Program on HIV/AIDS (UNAIDS). Fast-track-ending the AIDS epidemic by 2030. Geneva, Switzerland: UNAIDS; 2014.
4. Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell ML., High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013; 339 (6122): 966-71. doi: http://dx.doi.org/10.1126/science.1228160
5. Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N, et al., Final results of the HPTN 052 randomized controlled trial: antiretroviral therapy prevents HIV transmission. J Int AIDS Soc. 2015; 18 (Suppl 4): 20479. doi: http://dx.doi.org/10.7448/IAS.18.5.20479
6. Rodger A, Bruun T, Cambiano V, Vernazza P, Estrada V, van Lunzen J, et al., HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER Study. Proceedings of the 21st Conference on Retroviruses and Opportunistic Infections. Boston, MA; 2014 Mar 3-6.
7. Iwuji C, Orne-Gliemann J, Balestre E, Larmarange J, Thiebaut R, Tanser F, et al., The impact of universal test and treat on HIV incidence in a rural South African population: ANRS 12249 TasP trial, 2012-2016. Proceedings of the 21st International AIDS Conference. Durban, South Africa; 2016 July 18-22.
8. Joint United Nations Program on HIV/AIDS (UNAIDS). Prevention gap report. Geneva, Switzerland: UNAIDS; 2016.
9. World Health Organization. Consolidated guidelines on HIV testing services. Geneva, Switzerland: World Health Organization; 2016.
10. Siedner MJ, Ng CK, Basset IV, Katz IT, Bangsberg DR, Tsai AC., Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis. 2015; 60 (7): 1120-7.
11. The IeDEA and ART Cohort Collaborations. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014; 65 (1): e8-16.
12. Fisher M, Pao D, Brown AE, Sudarshi D, Gill ON, Cane P, et al., Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS. 2010; 24: 1739-47. doi: http://dx.doi.org/10.1097/QAD.0b013e32833ac9e6
13. Ratmann O, van Sighem A, Bezemer D, Gavryushkina A, Jurriaans S, Wensing A, et al., Sources of HIV infection among men having sex with men and implications for prevention. Sci Transl Med. 2016; 8 (320): 320. doi: http://dx.doi.org/10.1126/scitranslmed.aad1863
14. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al., Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010; 376: 532-9. doi: http://dx.doi.org/10.1016/S0140-6736(10)60936-1
15. Grebely J, Tyndall MW., Management of HCV and HIV infections among people who inject drugs. Curr Opin HIV AIDS. 2011; 6: 501-7. doi: http://dx.doi.org/10.1097/COH.0b013e32834bcb36
16. British Columbia Center for Disease Control. HIV and sexually transmitted infections 2010 annual surveillance report. Report no: HIV Surveillance: 604-707-5643 AIDS Case Reporting: 604-707-5643. Vancouver, Canada: BCCDC; 2010.
17. Boender TS, Sigaloff KC, McMahon JH, Kiertiburanakul S, Jordan MR, Barcarolo J, et al., Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2015; 61 (9): 1453-61. doi: http://dx.doi.org/10.1093/cid/civ556
18. Crepaz N, Tang T, Marks G, Mugavero MJ, Espinoza L, Hall HI., Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012-2013. Clin Infect Dis. 2016; 63 (7): 976-83. doi: http://dx.doi.org/10.1093/cid/ciw418
19. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG., Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009; 373 (9657): 48-57. doi: http://dx.doi.org/10.1016/S0140-6736(08)61697-9
20. Cook C, Lines R, Wilson DP., A no-brainer for ending AIDS: the case for a harm reduction decade. J Int AIDS Soc. 2016; 19 (1): 21129. doi: http://dx.doi.org/10.7448/IAS.19.1.21129
21. Godfrey-Faussett P., The HIV prevention cascade: more smoke than thunder? Lancet HIV. 2016; 3 (7): 286-8. doi: http://dx.doi.org/10.1016/S2352-3018(16)30062-5
22. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'reilly KR, Koechlin FM, et al., Effectiveness and safety of oral HIV pre-exposure prophylaxis (PrEP) for all populations: a systematic review and meta-analysis. AIDS. 2016; 30 (12): 1973-83. doi: http://dx.doi.org/10.1097/QAD.0000000000001145
23. Kamarulzaman A, Reid SE, Schwiters A, Wiessing L, El-Bassel N, Dolan K, et al., Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus and tuberculosis in prisoners. Lancet. 2016; 388 (10049): 1115-26. doi: http://dx.doi.org/10.1016/S0140-6736(16)30769-3
24. Joint United Nations Program on HIV/AIDS (UNAIDS). Cities ending the AIDS epidemic. Geneva, Switzerland: UNAIDS; 2016.